Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

NCT02557854 is registered in ClinicalTrials.gov with Theodore Laetsch as lead sponsor.

NCT NCT02557854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02557854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
Lead sponsor
Theodore Laetsch
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2016
Completion date
March 16, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid, neuroblastoma, osteosarcoma, rhabdomyosarcoma, sarcoma, sarcoma, ewing